AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2434976
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml of 0.5% bupivacaine
Trial: 2434976
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of 0.5% bupivacaine
Trial: 2434976
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of 0.5% tetracaine
Trial: 3011180
Drug: Lignocaine ointment
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lignocaine ointment
Trial: 15638067
Drug: Topical comfrey
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical comfrey product Traumaplant (10% active ingredient)
Trial: 8149361
Drug: Buspirone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (10 mg orally, twice a day)
Trial: 3243175
Drug: Furadantine MC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furadantine MC 100 mg tid
Trial: 3243175
Drug: Uridurine 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uridurine 100 mg tid
Trial: 3243175
Drug: Urfadyn PL
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urfadyn PL 100 mg bid
Trial: 3243175
Drug: Furadantine MC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furadantine MC 100 mg qid
Trial: 21763099
Drug: Scrambler therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scrambler therapy
Trial: 31364889
Drug: E2/P4 (1 mg/100 mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/P4 (1 mg/100 mg, 0.5 mg/100 mg, 0.5 mg/50 mg, 0.25 mg/50 mg)
Trial: 12923404
Drug: 0.3 mg/day
RxNorm normalized name: cloNIDine HCl 0.3 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/day moxonidine
Trial: 12923404
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day nitrendipine
Trial: 9988808
Drug: Sulindac (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac (200 mg orally every 12 hours for 6 doses)
Trial: 9988808
Drug: Terbutaline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (5 mg orally every 4 hours for 72 hours)
Trial: 2148827
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (IB) (0.5 mg)
Trial: 2148827
Drug: Home nebulizer
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home nebulizer treatment (salbutamol, ipratropium bromide, mixture)
Trial: 7437277
Drug: Dipyrone 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone 1.0 g (tooth extraction)
Trial: 7437277
Drug: Paracetamol 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1.0 g (tooth extraction)
Trial: 31902311
Drug: New Zealand
RxNorm normalized name: NEW ZEALAND GREEN MUSSEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New Zealand blackcurrant extract (600 mg·day-1 CurraNZ™)
Trial: 31902311
Drug: Placebo (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (600 mg microcrystalline cellulose)
Trial: 29788230
Drug: Trastuzumab/Pertuzumab-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab/Pertuzumab-based chemotherapy
Trial: 29692179
Drug: Intravenous belimumab
RxNorm normalized name: Belimumab
DrugBank: Belimumab (DB08879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous belimumab plus standard therapy
Trial: 29692179
Drug: Subcutaneous belimumab
RxNorm normalized name: Belimumab
DrugBank: Belimumab (DB08879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous belimumab plus standard therapy
Trial: 12082358
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (gonadotropin-releasing hormone) administered via four monthly injections and estradiol patch during testing
Trial: 7872446
Drug: Topical 1%
RxNorm normalized name: fluoride topical 1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 1% clotrimazole
Trial: 7872446
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% miconazole
Trial: 29447733
Drug: Stroke risk
RxNorm normalized name: Hep B, adolescent/high risk infant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stroke risk model based on older age, Killip class 3 or 4, estimated glomerular filtration rate ≤45 ml/min/1.73 m2, hypertension history, and previous stroke.
Trial: 18595128
Drug: 72 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 72 weeks of pegylated interferon and ribavirin treatment for genotype 1-infected slow responders
Trial: 18595128
Drug: 48 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 48 weeks of pegylated interferon and ribavirin treatment for genotype 1-infected slow responders
Trial: 12562461
Drug: Oral desensitization
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral desensitization treatment
Trial: 10836202
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy (ERT) with 50 micrograms/day of 17 beta‐estradiol
Trial: 9098205
Drug: Adenosine triphosphate
RxNorm normalized name: Adenosine triphosphate
DrugBank: ATP (DB00171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine triphosphate (ATP) at a dose of 0.16 mg/kg/min
Trial: 9098205
Drug: Dipyridamole (DIP)
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole (DIP) at a dose of 0.56 mg/kg
Trial: 8473679
Drug: BAY u
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY u 3405 (20 mg, single oral dose)
Trial: 28541645
Drug: Raloxifene 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 120 mg/d plus antipsychotics
Trial: 28541645
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus antipsychotics
Trial: 23557025
Drug: Doxycycline 20
RxNorm normalized name: doxycycline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 20 mg b.i.d. for 3 months
Trial: 20946157
Drug: Idrabiotaparinux (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idrabiotaparinux (3 mg)
Trial: 23078631
Drug: Idraparinux (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idraparinux (2.5 mg)
Trial: 12539808
Drug: Simvastatin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (all doses)
Trial: 10766085
Drug: Postoperative irradiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative irradiation combined with chemotherapy
Trial: 8793166
Drug: Moexipril 3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril 3.75 mg
Trial: 8793166
Drug: Moexipril 7.5
RxNorm normalized name: moexipril 7.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril 7.5 mg
Trial: 8793166
Drug: Moexipril 15
RxNorm normalized name: moexipril 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril 15 mg
Trial: 6699319
Drug: Jet nebulizer
RxNorm normalized name: Pari LC Jet Nebulizer Plus RE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet nebulizer therapy with metaproterenol sulfate solution 15 mg in 2.3 ml
Trial: 6699319
Drug: Canister therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canister therapy with metered-dose metaproterenol sulfate (total 1.95 mg)
Trial: 6699319
Drug: Jet nebulizer
RxNorm normalized name: Pari LC Jet Nebulizer Plus RE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet nebulizer therapy and Canister therapy
Trial: 26861468
Drug: Structured pharmacist
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured pharmacist review of medication (SPRM) with computerised clinical decision support software (CDSS)
Trial: 24371832
Drug: Water extracts
RxNorm normalized name: water birch pollen extract
DrugBank: Betula occidentalis pollen (DB10832)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water extracts of Graptopetalum paraguayense (WGP, 4 g/d)
Trial: 15499981
Drug: 1% ephedrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% ephedrine nosedrop, antibiotic, antihistamine, and anisodamine (10 mg twice a day)
Trial: 15499981
Drug: 1% ephedrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% ephedrine nosedrop, antibiotic, and antihistamine
Trial: 7710217
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 2 mg plus IM Ketorolac 30 mg (Group B)
Trial: 7710217
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 2 mg plus IM placebo (Group A)
Trial: 7710217
Drug: Epidural saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural saline placebo plus IM Ketorolac 30 mg (Group C)
Trial: 30195447
Drug: Mesalazine 3
RxNorm normalized name: mesalazine 375 MG 24 HR Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine 3 g once daily
Trial: 23188412
Drug: recombinant LH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant LH (r-LH) administration during late follicular development stages
Trial: 23188412
Drug: recombinant LH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant LH (r-LH) administration
Trial: 20651460
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Fe as ferric pyrophosphate
Trial: 20651460
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Fe as ferric pyrophosphate and 1.25 g DFAIII
Trial: 20651460
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Fe as ferrous sulfate
Trial: 19213340
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment + small dose prednisone
Trial: 19213340
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment + Chinese herbal medicine
Trial: 19213340
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment only (Control Group A)
Trial: 15798461
Drug: Glutamine-supplemented parenteral
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-supplemented parenteral nutrition (GlnPN; glutamine target intake, 0.4 g kg day; n = 41)
Trial: 15798461
Drug: Standard parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard parenteral nutrition (sPN; n = 39)
Trial: 12662915
Drug: Ethyl oleate
RxNorm normalized name: Ethyl Oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethyl oleate (EO) at 8 g/day in a single serving (approximately 0.1 g/kg)
Trial: 12662915
Drug: Ethyl oleate
RxNorm normalized name: Ethyl Oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethyl oleate (EO) at 16 g/day taken in two divided servings (approximately 0.2 g/kg)
Trial: 30672238
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with acupuncture combined with rehabilitation training
Trial: 26712382
Drug: Body weight‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body weight‐based prednisolone dosing
Trial: 26712382
Drug: Body surface
RxNorm normalized name: hepatitis B surface antigen vaccine Injection [Recombivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body surface area‐based prednisolone dosing
Trial: 23434957
Drug: Caudal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal analgesia with 0.75 ml/kg of 0.25% bupivacaine with 1 μg/kg of clonidine in normal saline (Group BC)
Trial: 23434957
Drug: Caudal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal analgesia with 0.75 ml/kg of 0.25% bupivacaine with ketamine 0.5 mg/kg (Group BK)
Trial: 23434957
Drug: Caudal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal analgesia with 0.75 ml/kg of 0.25% bupivacaine with fentanyl 1 mcg/kg (Group BF)
Trial: 23434957
Drug: Caudal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal analgesia with 0.75 ml/kg of 0.25% bupivacaine in normal saline (Group B)
Trial: 20378497
Drug: L-LV (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-LV (100 mg/m2)
Trial: 20378497
Drug: DL-LV (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DL-LV (200 mg/m2)
Trial: 15843938
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of oral antibiotics (neomycin and metronidazole) at the time of mechanical colon cleansing
Trial: 15843938
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of oral antibiotics
Trial: 29684391
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral antibiotics
Trial: 10605328
Drug: Nifidipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifidipine GITS 30 and 60 mg
Trial: 9166464
Drug: Adjuvant CMF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant CMF (cyclophosphamide, methotrexate, fluorouracil) chemotherapy for 6 months
Trial: 1932652
Drug: Cardioplegic solution
RxNorm normalized name: cardioplegic solution no.2
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardioplegic solution enriched with creatine phosphate (10 mmol/L)
Trial: 31658994
Drug: Ipilimumab with
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab with concurrent stereotactic radiation therapy (50 Gy in 4 fractions)
Trial: 31658994
Drug: Ipilimumab with
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab with sequential stereotactic radiation therapy (60 Gy in 10 fractions)
Trial: 31658994
Drug: Sequential lung
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential lung group
Trial: 26934128
Drug: Premixed insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premixed insulin lispro protamine suspension 75%/insulin lispro solution 25% (LM25) twice daily (bid)
Trial: 26934128
Drug: Basal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal insulin glargine plus prandial insulin lispro (IGL), once daily
Trial: 23046566
Drug: JUC (nanotechnology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JUC (nanotechnology antimicrobial spray)
Trial: 15947981
Drug: Theophylline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (5 mg/kg; study group: n=20)
Trial: 11812509
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (0.2, 0.4, and 0.8 mg)
Trial: 11812509
Drug: D-amphetamine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-amphetamine (15 mg, oral)
Trial: 9916865
Drug: Insulin-tolerance test
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-tolerance test (ITT)
Trial: 2647495
Drug: gallopamil 75
RxNorm normalized name: gallopamil
DrugBank: Gallopamil (DB12923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gallopamil 75 mg t.i.d.
Trial: 29174683
Drug: HZ/su administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HZ/su administered 0, 6-month schedule
Trial: 29174683
Drug: HZ/su administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HZ/su administered 0, 12-month schedule
Trial: 29174683
Drug: All dosing
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All dosing intervals
Trial: 26294706
Drug: Integrated mental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated mental health and substance abuse treatments for at least the first 3 years
Trial: 1352428
Drug: Apraclonidine 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apraclonidine 1% instilled one hour before and immediately after laser treatment
Trial: 6725520
Drug: 1.5 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 micrograms/kg oral clonidine
Trial: 6725520
Drug: 5.0 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 micrograms/kg oral clonidine
Trial: 30103220
Drug: Single-dose Azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Single-dose Azithromycin
Trial: 27344826
Drug: Fluoxetine hydrochloride
RxNorm normalized name: Fluoxetine Hydrochloride
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine hydrochloride capsules (oral administration, once a day for 4 weeks)
Trial: 25012999
Drug: Task-specific training
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Task-specific training conducted by physical therapists in participants' homes, focusing on walking, sit-to-stand transfers, and standing, twice a week for 8 weeks.
Trial: 20484057
Drug: DHEA 50
RxNorm normalized name: Natrol Mood & Stress DHEA 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 50 mg/day for 6 months
Trial: 18584574
Drug: Levetiracetam (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (2000 mg daily for 10 weeks)
Trial: 15975721
Drug: Veno-venous continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veno-venous continuous renal replacement therapy (CRRT)
Trial: 12468480
Drug: Informing participants
RxNorm normalized name: INFORMATION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Informing participants of their treatment allocation at trial closure
Trial: 12468480
Drug: Not informing
RxNorm normalized name: INFORMATION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not informing participants of their treatment allocation at trial closure
Trial: 9799054
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg pantoprazole p.o. once daily for 11 days
Trial: 7617798
Drug: Oral ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ethanol (1.1 ml/kg 95% ethanol as a 20% solution)
Trial: 7617798
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of ethanol and yohimbine
Trial: 325238
Drug: Propoxyphene napsylate
RxNorm normalized name: Propoxyphene Napsylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propoxyphene napsylate (50 or 100 mg)
Trial: 325238
Drug: Codeine sulfate
RxNorm normalized name: Codeine Sulfate
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Codeine sulfate (30 or 60 mg)
Trial: 28374923
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) supplementation, 2 g/day for 9 weeks
Trial: 23617452
Drug: Empagliflozin 200
RxNorm normalized name: Empagliflozin
DrugBank: Empagliflozin (DB09038)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Empagliflozin 200 mg
Trial: 21718491
Drug: Ischemic preconditioning
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ischemic preconditioning (IPC) administered 4 hours prior to ischemia
Trial: 21718491
Drug: Ischemic preconditioning
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ischemic preconditioning (IPC) administered 48 hours prior to ischemia
Trial: 11114494
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg buspirone
Trial: 17329302
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg buspirone
Trial: 11236537
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy (six series of polychemotherapy with cisplatin 50 mg/m2, adriamycin 50 mg/m2, and cyclophosphamide 500 mg/m2)
Trial: 8286880
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (39 mg/day)
Trial: 2424279
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (5,000 IU X 2 s.c.) started preoperatively and continued daily for one week post-operatively
Trial: 2424279
Drug: Per-operative electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Per-operative electrical calf muscle stimulation with groups of impulses plus post-operative dextran infusions every other day for one week